Brevel

Company Overview

Snapshot

Founded in February 2017 by Yonatan Golan, Matan Golan, and Ido Golan, Brevel operates with 11–50 employees. The company has secured $35.9 million in total capital raised across 8 funding rounds from 9 investors. In May 2026, Brevel received a grant from the BIRD Foundation.

Business overview

Brevel is a climate food-tech company that develops a neutral-flavored and sustainable alternative protein from microalgae. Its core technology combines sugar-based fermentation with high-intensity light to produce microalgae rich in functionalities, suitable for animal-free dairy, egg, meat, and seafood alternatives. Brevel serves the food and beverage industry, operating within the sustainable proteins, novel food & ingredients, and sustainable materials & circularity sectors.

Strategic signal

In March 2026, Brevel introduced Purallis™, a clean-label chlorella cultivated using its proprietary illuminated fermentation technology. This launch is significant as it addresses the growing demand for pure and standardized chlorella in the nutraceutical space, showcasing Brevel's ability to innovate and scale its microalgae production for diverse applications beyond alternative proteins. This signals to investors a broadening market opportunity and a validated, scalable production method for high-value ingredients.

Company Intelligence Q&A

What was a significant recent funding event for Brevel?

In March 2025, Brevel raised over $5 million in Seed funding, bringing the total for that round to $25 million. This funding was backed by NevaTeam Partners and Siddhi Capital.

What strategic partnership did Brevel recently establish?

In February 2025, Brevel signed a 10-year development and commercialization agreement with The Central Bottling Company (CBC Group), Israel's largest beverage company. This partnership aims to develop functional beverages and dairy alternatives using Brevel's microalgae protein and oils.

What new product did Brevel launch in March 2026?

In March 2026, Brevel introduced Purallis™, a clean-label chlorella for the nutraceutical space. This product is cultivated using Brevel's proprietary illuminated fermentation technology, ensuring purity and standardization for health and wellness applications.

What was Brevel's total capital raised as of its last update?

Brevel has raised a total of $35.9 million across its funding rounds.

What was a key development for Brevel in July 2023?

In July 2023, Brevel secured seed funding from investors including NevaTeam Partners and the European Union’s. This funding was intended for the continued development of its microalgae protein, particularly focusing on the dairy alternative sector.